Overview
CNMD market data
Price History
CNMD price chart
Valuation & Profitability
- P/E (TTM)
- 20.10 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.51 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.95 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 225.4% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $33.21 – $60.80 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.1K · P/B 1.22 · P/S 0.80.
Company news
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - Analysis by Product, Surgery, End User and RegionGlobenewswire Inc · Jul 24, 2026, 3:15 PM
CONMED Says AirSeal Robotic Solution Is Now Indicated For Use With Intuitive’s 8 mm Hex Cannulas Used As Part Of Intuitive Da Vinci 5 PlatformBenzinga · Jul 22, 2026, 11:11 AM
TriCo Bancshares, Verra Mobility, Park Aerospace And Other Big Stocks Moving Higher On MondayBenzinga · Jul 13, 2026, 1:58 PM
BMO Capital Initiates Coverage On Conmed with Market Perform Rating, Announces Price Target of $36Benzinga · Jul 9, 2026, 3:01 PM
B of A Securities Downgrades Conmed to Underperform, Maintains Price Target to $40Benzinga · Jun 29, 2026, 11:15 AM
CONMED Appoints John E. Gallagher CFO, Effective July 15, Succeeding Todd GarnerBenzinga · Jun 17, 2026, 8:40 PM
8-K filing — CONMED Corp (CNMD)SEC EDGAR · Jun 4, 2026, 11:30 AM
B of A Securities Maintains Neutral on Conmed, Lowers Price Target to $40Benzinga · May 18, 2026, 5:45 PM